Search Results - "Scalese, M."

Factors reducing omalizumab response in severe asthma by Sposato, B., Scalese, M., Milanese, M., Masieri, S., Cavaliere, C., Latorre, M., Scichilone, N., Matucci, A., Vultaggio, A., Ricci, A., Cresti, A., Santus, P., Perrella, A., Paggiaro, P.L.

“…Despite adding Omalizumab to conventional therapy, several severe asthmatics still show poor disease control. We investigated the factors that may affect a…”
Get full text

Hypercalciuria: its value as a predictive risk factor for nephrolithiasis in asymptomatic primary hyperparathyroidism? by Saponaro, F., Cetani, F., Mazoni, L., Apicella, M., Di Giulio, M., Carlucci, F., Scalese, M., Pardi, E., Borsari, S., Bilezikian, J. P., Marcocci, C.

“…Context The latest guidelines of the 4th International Workshop on Asymptomatic Primary Hyperparathyroidism (aPHPT) reintroduced hypercalciuria (i.e. urinary…”
Get full text

Clinical presentation and management of patients with primary hyperparathyroidism in Italy by Saponaro, F., Cetani, F., Repaci, A., Pagotto, U., Cipriani, C., Pepe, J., Minisola, S., Cipri, C., Vescini, F., Scillitani, A., Salcuni, A., Palmieri, S., Eller-Vainicher, C., Chiodini, I., Madeo, B., Kara, E., Castellano, E., Borretta, G., Gianotti, L., Romanelli, F., Camozzi, V., Faggiano, A., Corbetta, S., Cianferotti, L., Brandi, M. L., De Feo, M. L., Palermo, A., Vezzoli, G., Maino, F., Scalese, M., Marcocci, C.

“…Purpose Evaluation of the phenotype of primary hyperparathyroidism (PHPT), adherence to International Guidelines for parathyroidectomy (PTx), and rate of…”
Get full text

Severe asthma and long-term Benralizumab effectiveness in real-life by Sposato, B, Scalese, M, Camiciottoli, G, Carpagnano, G E, Pelaia, C, Santus, P, Pelaia, G, Palmiero, G, Di Tomassi, M, Ronchi, M C, Cameli, P, Bargagli, E, Ciambellotti, L, Rizzello, S, Sglavo, R, Coppola, A, Lacerenza, L G, Gabriele, M, Radovanovic, D, Perrella, A, Ricci, A, Rogliani, P

“…Long-term efficacy of Benralizumab in real life is not clearly known. We assessed the long-term effectiveness persistence to anti-IL-5R treatment in a group of…”
Get more information

Using Likelihood Ratios to Detect Invalid Performance with Performance Validity Measures by Meyers, John E., Miller, Ronald M., Thompson, Lisa M., Scalese, Adam M., Allred, Bonnie C., Rupp, Zachary W., Dupaix, Zacharias P., Junghyun Lee, Amy

“…Larrabee (2008) applied chained likelihood ratios to selected performance validity measures (PVMs) to identify non-valid performances on neuropsychological…”
Get full text

Effects of omalizumab in severe asthmatics across ages: A real life Italian experience by Sposato, B, Scalese, M, Latorre, M, Scichilone, N, Matucci, A, Milanese, M, Masieri, S, Rolla, G, Steinhilber, G, Rosati, Y, Vultaggio, A, Folletti, I, Baglioni, S, Bargagli, E, Di Tomassi, M, Pio, R, Pio, A, Maccari, U, Maggiorelli, C, Migliorini, M.G, Vignale, L, Pulerà, N, Carpagnano, G.E, Foschino Barbaro, M.P, Perrella, A, Paggiaro, P.L

“…Abstract Background This retrospective study aimed at evaluating long-term effects of Omalizumab in elderly asthmatics in a real-life setting. Methods 105…”
Get full text

Should omalizumab be used in severe asthma/COPD overlap? by Sposato, B, Scalese, M, Milanese, M, Masieri, S, Cavaliere, C, Ricci, A, Paggiaro, P

“…A large number of patients suffering from asthma or chronic obstructive pulmonary disease (COPD) can show overlapping features of both diseases. Several…”
Get more information

Influence of allergic status and nasal polyposis on long-term Benralizumab response in eosinophilic severe asthma by Sposato, B, Ricci, A, Camiciottoli, G, Carpagnano, G E, Pelaia, C, Santus, P, Pelaia, G, Palmiero, G, Di Tomassi, M, Ronchi, M C, Cameli, P, Bargagli, E, Ciambellotti, L, Rizzello, S, Sglavo, R, Coppola, A, Lacerenza, L G, Gabriele, M, Radovanovic, D, Perrella, A, Rogliani, P, Scalese, M

“…It is unclear whether Benralizumab effectiveness in severe eosinophilic asthma can be influenced by nasal polyposis (NP) or allergic status associations. We…”
Get more information

Normal Values of the Mitral-Aortic Intervalvular Fibrosa Thickness: A Multimodality Study by Cresti, Alberto, Baratta, Pasquale, De Sensi, Francesco, Solari, Marco, Sposato, Bruno, Minelli, Stefano, Cioffi, Nevada, Franci, Luca, Scalese, M., Limbruno, Ugo

Get full text

How to predict new-onset atrial fibrillation in STEMI patients treated by primary percutaneous coronary intervention: The ALBO score by Mazzone, A., Scalese, M., Paradossi, U., Del Turco, S., Botto, N., De Caterina, A., Trianni, G., Ravani, M., Rizza, A., Molinaro, S., Palmieri, C., Berti, S., Basta, G.

“…Objective: Biomarkers are useful to identify individuals at risk of developing new-onset atrial fibrillation (NOAF) in patients with hypertensive…”
Get full text

Glucose Fluctuations during Gestation: An Additional Tool for Monitoring Pregnancy Complicated by Diabetes by Giovanni, Sartore, Annunziata, Lapolla, Dalfrà, Maria Grazia, Scalese, M., Biagioni, S., Lencioni, Cristina, Chilelli, N. C., Di Cianni, Graziano, Mello, G.

“…Continuous glucose monitoring (CGM) gives a unique insight into magnitude and duration of daily glucose fluctuations. Limited data are available on glucose…”
Get full text

Could a vitamin D deficiency cause a combined long-term FEV1 and bone mineral density deterioration in female asthmatics? by Sposato, B, Scalese, M, Petruzzelli, L, Baldini, E, Nikiforakis, N, Tosti Balducci, M

“…We already know that asthma is associated to osteoporosis/osteopenia and characterized by an accelerated lung function decline. Our study aimed at assessing…”
Get more information

Can we modulate asthma maintenance treatment level with disease seasonal variations? by Sposato, B, Scalese, M, Moschini, G, Migliorini, M G

“…Asthma can have clinical seasonal fluctuations due to different exposure factors. The analysis of our data and literature confirm a seasonal trend of asthma…”
Get more information

Real-life Mepolizumab effectiveness in severe eosinophilic asthmatics with nasal polyposis by Sposato, B., Scalese, M., Camiciottoli, G., Carpagnano, G.E., Pelaia, C., Santus, P., Maniscalco, M., Corsico, A., Grosso, A., Baglioni, S., Murgia, N., Folletti, I., Pelaia, G., Masieri, S., Cavaliere, C., Musarra, A., Bargagli, E., Ricci, A., Latorre, M., Rogliani, P., Paggiaro, P.

Get full text

Different Skin Prick Test Sensitization Patterns Do Not Influence the Response to Omalizumab in Severe Asthma by Sposato, B, Scalese, M, Milanese, M, Masieri, S, Cavaliere, C, Latorre, M, Scichilone, N, Matucci, A, Vultaggio, A, Ricci, A, Cresti, A, Paggiaro, P L

Get full text

Cypress pollen: an unexpected major sensitizing agent in different regions of Italy by Sposato, B, Liccardi, G, Russo, M, Folletti, I, Siracusa, A, Scichilone, N, Ventura, M T, Rolla, G, Raie, A, Milanese, M, Pio, R, Pio, A, Scala, R, Pareo, C, Micucci, C, Micheletto, C, Billeri, L, Musarra, A, Cavaliere, C, Agolli, G, Masieri, S, Scalese, M, Capitani, D

“…In this multicenter survey, we assessed the impact of sensitization to cypress in atopic patients in Italy and determined whether cypress pollen concentration…”
Get full text

Thyroid hormone, amiodarone therapy, and prognosis in left ventricular systolic dysfunction by Coceani, M., Molinaro, S., Scalese, M., Landi, P., Carpeggiani, C., L’Abbate, A., Iervasi, G., Pingitore, A.

“…Background : Amiodarone protects patients with left ventricular systolic dysfunction (LVSD) against serious arrhythmias, but it also has numerous side effects…”
Get full text

Safety and efficacy of low-energy cardioversion of 500 patients using two different techniques by Andraghetti, A, Scalese, M

“…To present some safety and efficacy issues of low-energy internal cardioversion of chronic atrial fibrillation from 500 consecutive procedures performed with…”
Get full text

A regular or an intermittent treatment for asthma: the long-term effect by Sposato, B, Pammolli, A, Bove, L, Barzan, R, Ricci, A, Scalese, M, Marioita, S, Franco, C

“…Many asthmatics take therapy intermittently because of their scarce compliance. It is not known if this is effective in controlling and slowing down the lung…”
Get more information

Systemic cytokine administration can affect blood-brain barrier permeability in the rat by Saija, A, Princi, P, Lanza, M, Scalese, M, Aramnejad, E, De Sarro, A

“…The aim of the present study was to clarify the effect of intracarotid injection of interleukin-1 beta (IL-1 beta), interleukin-2 (IL-2), interleukin-6 (IL-6)…”
Get more information